WHF Position Statement on COVID Vaccination.
COVID vaccination
cardiovascular disease
global health
Journal
Global heart
ISSN: 2211-8179
Titre abrégé: Glob Heart
Pays: England
ID NLM: 101584391
Informations de publication
Date de publication:
27 04 2021
27 04 2021
Historique:
entrez:
27
5
2021
pubmed:
28
5
2021
medline:
8
6
2021
Statut:
epublish
Résumé
The current COVID-19 pandemic has challenged health systems and communities globally. As such, several countries have embarked on national COVID-19 vaccination programmes in order to curb spread of the disease. However, at present, there isn't yet enough dosages to enable vaccination of the general population. Different vaccine prioritization strategies are thus being implemented in different communities in order to permit for a systematic vaccination of individuals. Here, on behalf of the World Heart Federation, we emphasize the need for individuals with Cardiovascular disease to be prioritized in national vaccine prioritization programmes as these are high risk individuals.
Identifiants
pubmed: 34040942
doi: 10.5334/gh.1027
pmc: PMC8086730
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Pagination
29Subventions
Organisme : FIC NIH HHS
ID : K43 TW011164
Pays : United States
Informations de copyright
Copyright: © 2021 The Author(s).
Déclaration de conflit d'intérêts
The authors have no competing interests to declare.
Références
S Afr Med J. 2020 Jun 25;110(8):709-710
pubmed: 32880289
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Nat Rev Microbiol. 2021 Mar;19(3):155-170
pubmed: 33116300
Cells. 2020 Nov 19;9(11):
pubmed: 33228225
N Engl J Med. 2013 May 23;368(21):2004-13
pubmed: 23697515
Nat Rev Endocrinol. 2021 Jan;17(1):11-30
pubmed: 33188364
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371
pubmed: 32201335
Diabetes Care. 2008 Feb;31 Suppl 2:S185-9
pubmed: 18227483
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Nature. 2021 Feb;590(7845):197
pubmed: 33547434
JAMA Cardiol. 2020 Jul 1;5(7):831-840
pubmed: 32219363
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
N Engl J Med. 2020 Dec 17;383(25):2439-2450
pubmed: 33053279
Cell Death Differ. 2021 Feb;28(2):626-639
pubmed: 33479399
J Am Coll Cardiol. 2017 Jul 4;70(1):1-25
pubmed: 28527533
Circ Res. 2020 May 8;126(10):1456-1474
pubmed: 32264791
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Mil Med Res. 2020 Mar 13;7(1):11
pubmed: 32169119
Immunity. 2010 Oct 29;33(4):504-15
pubmed: 21029961
Biol Lett. 2008 Apr 23;4(2):176-8
pubmed: 18089519
J Infect. 2021 Apr;82(4):e8-e10
pubmed: 33472093
Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7809-14
pubmed: 18490652
J Virol. 2014 Aug;88(15):8597-614
pubmed: 24850731
Eur Heart J. 2017 Nov 14;38(43):3195-3201
pubmed: 29020241
PLoS One. 2012;7(10):e47323
pubmed: 23115643
Indian J Med Res. 2013 Nov;138(5):779-95
pubmed: 24434331
Circulation. 2020 May 19;141(20):1648-1655
pubmed: 32200663
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Clin Res Cardiol. 2020 Dec;109(12):1446-1459
pubmed: 32462267
Clin Res Cardiol. 2020 Dec;109(12):1460-1468
pubmed: 32809116
Infection. 2020 Oct;48(5):773-777
pubmed: 32277408
J Autoimmun. 2020 Jul;111:102468
pubmed: 32317220
Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):709-725
pubmed: 29437578
Front Microbiol. 2020 Feb 28;11:298
pubmed: 32265848
J Virol. 2010 Jan;84(2):1198-205
pubmed: 19864379